首页> Clinical rheumatology> Insulin use and gout risk among patients with type 2 diabetes mellitus: a real-world cohort study in Shanghai, China.

Insulin use and gout risk among patients with type 2 diabetes mellitus: a real-world cohort study in Shanghai, China.

导出原文传递

翻译打印收藏纠错

第一作者： Jiying,Qi

第一单位： Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.;Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

作者： Jiying,Qi ^[1] ; Ping,He ^[2] ; Huayan,Yao ^[3] ; Wen,Sun ^[4] ; Ping,Lu ^[4] ; Xiaohui,Qi ^[1] ; Zizheng,Zhang ^[1] ; Renjie,Jing ^[1] ; Bin,Cui ^[5] ; Dongmei,Liu ^[6] ; Guang,Ning ^[7]

作者单位： Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.;Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. ^[1] Link Healthcare Engineering and Information Department, Shanghai Hospital Development Center, Shanghai, China. ^[2] Computer Net Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. ^[3] Wonders Information Co. Ltd, Shanghai, China. ^[4] Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. cb11302@rjh.com.cn.;Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. cb11302@rjh.com.cn. ^[5] Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China. liudm0103@163.com. ^[6] Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. gning@sibs.ac.cn.;Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. gning@sibs.ac.cn. ^[7]

关键词 Gout Insulin Real-world study Type 2 diabetes mellitus